Yann-Alexandre Vano (Yann A Vano, Yann Vano)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 13

Top Topics

Combination Therapy

Systematic Review

Renal Cell Carcinoma

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer research

World journal of urology

This page only lists publications with an associated author ORCID identifier.

Publications

Omar Alhalabi, Jonathan Thouvenin, Sylvie Négrier, Yann-Alexandre Vano, Luca Campedel, Elshad Hasanov, Ziad Bakouny, Andrew W Hahn, Mehmet Asim Bilen, Pavlos Msaouel, Toni K Choueiri, Srinivas R Viswanathan, Kanishka Sircar, Laurence Albiges, Gabriel G Malouf, Nizar M Tannir
Immune Checkpoint Therapy Combinations in Adult Advanced MiT Family Translocation Renal Cell Carcinomas. The oncologist (2023)
Guillaume Davidson, Alexandra Helleux, Yann-Alexandre Vano, Veronique Lindner, Antonin Fattori, Marie Cerciat, Reza-Thierry Elaidi, Virginie Verkarre, Cheng-Ming Sun, Christine Chevreau, Mostefa Bennamoun, Hervé Lang, Thibault Tricard, Wolf Herman Fridman, Catherine Sautès-Fridman, Xiaoping Su, Damien Plassard, Céline Keime, Christelle Thibault-Carpentier, Philippe Barthélémy, Stephane Marie Oudard, Irwin Davidson, Gabriel G Malouf
Mesenchymal-like tumor cells and myofibroblastic cancer-associated fibroblasts are associated with progression and immunotherapy response of clear-cell renal cell carcinoma. Cancer research (2023)
Nadine Benhamouda, Ikuan Sam, Nicolas Epaillard, Alain Gey, Letuan Phan, Hang-Phuong Pham, Nadège Gruel, Antonin Saldman, Joséphine Pineau, Milena Hasan, Valentin Quiniou, Camille Nevoret, Virginie Verkarre, Valentina Libri, Sébastien Mella, Clémence Granier, Chloe Broudin, Patrice Ravel, Eléonore De Guillebon, Laetitia Mauge, Dominique Helley, Bernd Jagla, Nathalie Chaput, Laurence Albiges, Sandrine Katsahian, Julien Adam, Arnaud Mejean, Olivier Adotévi, Yann-Alexandre Vano, Stephane Marie Oudard, Eric Tartour
Plasma CD27, a Surrogate of the Intratumoral CD27-CD70 Interaction, Correlates with Immunotherapy Resistance in Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (22) (2022)
Yann-Alexandre Vano, Letuan Phan, Gwenaelle Gravis, Iphigénie Korakis, Friederike Schlürmann, Denis Maillet, Mostefa Bennamoun, Nadine Houede, Delphine Topart, Delphine Borchiellini, Philippe Barthelemy, Raffaele Ratta, Thomas Ryckewaert, Ali Hasbini, Sophie Hans, Sheik Emambux, Sandra Cournier, Elena Braychenko, Réza-Thierry Elaidi, Stéphane Oudard
Cabozantinib-nivolumab sequence in metastatic renal cell carcinoma: The CABIR study. International journal of cancer 151 (8) (2022)
Robert J Motzer, Toni K Choueiri, David F McDermott, Thomas Powles, Yann-Alexandre Vano, Saurabh Gupta, Jin Yao, Celine Han, Ron Ammar, Simon Papillon-Cavanagh, Shruti S Saggi, M Brent McHenry, Petra Ross-MacDonald, Megan Wind-Rotolo
Biomarker analysis from CheckMate 214: nivolumab plus ipilimumab versus sunitinib in renal cell carcinoma. Journal for immunotherapy of cancer 10 (3) (2022)
Zoé Guillaume, Marie Auvray, Yann-Alexandre Vano, Stephane Marie Oudard, Dominique Helley, Laetitia Mauge
Renal Carcinoma and Angiogenesis: Therapeutic Target and Biomarkers of Response in Current Therapies. Cancers 14 (24) (2022)
Xiaofan Lu, Yann-Alexandre Vano, Alexandra Helleux, Xiaoping Su, Veronique Lindner, Guillaume Davidson, Roger Mouawad, Jean-Philippe Spano, Morgan Roupret, Reza-Thierry Elaidi, Eva M Comperat, Virginie Verkarre, Cheng-Ming Sun, Christine Chevreau, Mostefa Bennamoun, Hervé Lang, Thibault Tricard, Wenxuan Cheng, Li Xu, Irwin Davidson, Fangrong Yan, Wolf Herman Fridman, Catherine Sautès-Fridman, Stephane Marie Oudard, Gabriel G Malouf
An enhancer demethylator phenotype converged to immune dysfunction and resistance to immune checkpoint inhibitors in clear-cell renal cell carcinomas. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Zoé Guillaume, Marie Auvray, Yann-Alexandre Vano, Stephane Marie Oudard, Dominique Helley, Laetitia Mauge
Renal Carcinoma and Angiogenesis: Therapeutic Target and Biomarkers of Response in Current Therapies. Cancers 14 (24) (2022)
Audrey Simonaggio, Damien Ambrosetti, Virginie Verkarre, Marie Auvray Kuentz, Stephane Marie Oudard, Yann-Alexandre Vano
MiTF/TFE Translocation Renal Cell Carcinomas: From Clinical Entities to Molecular Insights. International journal of molecular sciences 23 (14) (2022)
Yann-Alexandre Vano, Sylvain Ladoire, Réza Elaidi, Slimane Dermeche, Jean-Christophe Eymard, Sabrina Falkowski, Marine Gross-Goupil, Gabriel Malouf, Bérangère Narciso, Christophe Sajous, Sophie Tartas, Eric Voog, Alain Ravaud
First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma: What Are the Most Appropriate Combination Therapies? Cancers 13 (21) (2021)
Ivan Pourmir, Johanna Noel, Audrey Simonaggio, Stéphane Oudard, Yann-Alexandre Vano
Update on the most promising biomarkers of response to immune checkpoint inhibitors in clear cell renal cell carcinoma. World journal of urology 39 (5) (2021)
Reza-Thierry Elaidi, Letuan Phan, Delphine Borchiellini, Philippe Barthelemy, Alain Ravaud, Stéphane Oudard, Yann-Alexandre Vano
Comparative Efficacy of First-Line Immune-Based Combination Therapies in Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-Analysis. Cancers 12 (6) (2020)
Yann-Alexandre Vano, Stéphane Oudard, Marie-Agnès By, Pauline Têtu, Constance Thibault, Hail Aboudagga, Florian Scotté, Reza Elaidi
Optimal cut-off for neutrophil-to-lymphocyte ratio: Fact or Fantasy? A prospective cohort study in metastatic cancer patients. PloS one 13 (4) (2018)